Overnight US stocks | The three major indices rose this week. NVIDIA Corporation (NVDA.US) fell 13% this week, with its market capitalization dropping below the US$40,000 threshold.

At the close, the Dow rose 50.46 points, or 0.10%, to 52,347.55; the S&P 500 fell 30.73 points, or 0.40%, to 7,561.67; and the Nasdaq fell 229.82 points, or 0.91%, to 25,136.27.

59 m ago

Barclays turns tactically bullish on US stocks for the first time since March; recent selloff has created conditions for a short-term rebound.

As investors sharply cut equity positions and market volatility pressure eased somewhat, Barclays' trading desk turned tactically bullish on US stocks for the first time since mid-March this year.

59 m ago

Persistent inflation pressures keep expectations for consecutive Federal Reserve rate hikes rising; AI investment risks heighten concerns over financial stability.

As U.S. inflation accelerated again, Federal Reserve officials? No As U.S. inflation accelerated again, Federal Reserve officials this week? Let's produce clean As U.S. inflation accelerated again, Federal Reserve officials this week issued a? No. Final: As U.S. inflation accelerated again, Federal Reserve officials this week? Stop. Correct As U.S. inflation accelerated again, Federal Reserve officials this week? I'll write: As U.S. inflation accelerated again, Federal Reserve officials this week? No"" = "intensively signaled a hawkish stance." Final: As U.S. inflation accelerated again, Federal Reserve officials this week intensively signaled a hawkish stance, further strengthening market expectations for a December rate hike and opening the door to another rate increase in January next year.

59 m ago

US Stock Market Move | NVIDIA Corporation (NVDA.US) opened higher but closed lower, falling more than 4%; a well-known investment bank says there is still considerable uncertainty surrounding management changes.

On Friday, NVIDIA Corporation (NVDA.US) opened higher in early trading but reversed course and is now down more than 4%, at US$159.40.

8 h ago

US Stock Market Move | Fed Officials Turn Hawkish Again; Philadelphia Semiconductor Index Falls Over 5%, Semiconductor Sector Declines Broadly

On Friday, the Philadelphia Semiconductor Index fell over 5%, with the semiconductor sector declining broadly.

8 h ago

A-share Evening Highlights | October social financing and M2 growth both exceed 7%; US October core PPI up 5% year-on-year

On November 13, the central bank released October financial data, with both the outstanding stock of social financing and M2 year-on-year growth exceeding 7%.

8 h ago

GOFINTECH QUANT (00290) plans to sell a 22.50% equity stake in CSOP Asset Management Limited for HK$1.2 billion, focusing on its own proprietary public fund business.

GOFINTECH QUANT (00290) announced that on November 13, 2026, the company intends to sell a 22.50% equity stake in CSOP Asset Management Limited to CPCT Limited for a cash consideration of HK$1.2 billion. In addition, the company has the right to receive a permitted dividend under the share purchase agreement (a contingent right that does not form part of the consideration). The permitted dividend refers to dividends declared by the target company from the undistributed profits attributable to the sale shares, provided that the total amount of the permitted dividend shall not exceed approximately HK$251 million.

8 h ago

WAI CHUN BIOTEC (00660) Announces Annual Results, Profit Attributable to Shareholders HK$7.205 million, Trading Resumes on November 16

WAI CHUN BIOTEC (00660) announced its annual results for the year ended June 30, 2026, with revenue of HK$405 million, up 7.3% year-on-year; profit attributable to owners of the company of HK$7.205 million, compared with a loss of HK$14.623 million in the same period last year; basic earnings per share of 3.40 HK cents.

9 h ago

US Stock Market Move | Apple Inc. (AAPL.US) rose nearly 2% to hit another all-time high, becoming Wall Street's top choice for hedging AI risk.

On Friday, Apple (AAPL.US) rose nearly 2% in early trading to hit another all-time high, bringing its year-to-date gain to 32%, with a total market capitalization of US$5.23 trillion.

9 h ago

US Stock Market Move | Modine Manufacturing Company (MOD.US) surged over 32% at the open on reports that Samsung Electronics is in talks to acquire it.

On Friday, Modine Manufacturing Company (MOD.US) surged over 32% at the open and is now trading at $141.72.

9 h ago

PROSP INV HOLD (00310): Consolidated net asset value per share at the end of October was approximately HK$0.026.

PROSP INV HOLD (00310) announced that the unaudited consolidated net asset value per share of the company as at 31 October 2026 was approximately HK$0.026.

9 h ago

TIAN CHANG GP (02182) subsidiary intends to acquire 7 injection molding machines.

TIAN CHANG GP (02182) announced that on November 13, 2026, Huizhou Tianchang (an indirectly wholly-owned subsidiary of the Company) placed a purchase order with Seller B (Haitian Plastics Machinery Group Co., Ltd.), with the total consideration for the acquisition being RMB6.9 million. The machines procured are 7 injection molding machines.

9 h ago

US Stock Market Move | Q3 results beat expectations, Cerebras (CBRS.US) surges over 12% in premarket trading.

On Friday, Cerebras (CBRS.US) surged over 12% in premarket trading and is now at $110.26.

9 h ago

CDB LEASING (01606) plans to purchase IT computer equipment for RMB981 million.

CDB LEASING (01606) announced that the Company, as buyer, entered into the product procurement agreement on November 13, 2026 with the seller (Guangdong Shuhuan Zhilian Technology Co., Ltd.), pursuant to which the seller agreed to sell and the buyer agreed to purchase the subject matter of this procurement for a total consideration of approximately RMB981 million. The subject matter of this procurement is IT computer equipment.

9 h ago

EMPEROR INT'L (00163) plans to sell the UK's Ampersand Building for GBP159.2 million

EMPEROR INT'L (00163) announced that after the trading session on November 13, 2026, the Company's indirectly wholly-owned subsidiary, Grand Mark Group Limited, intends to sell to Northstar Ampersand Propco Limited the entire equity interests in and repayment of shareholder loans of Emperor Ampersand General Partner S. r.l. and Emperor Ampersand S. r.l., for a total consideration of approximately GBP159.2 million.

9 h ago

CWT INT'L (00521): Its subsidiary has entered into agreements and instruments to carry out internal restructuring steps.

CWT INT'L (00521) announced that subsidiaries of the Group entered into agreements and instruments on November 13, 2026 to carry out internal restructuring steps (the Internal Restructuring).

9 h ago

US Stock Market Move | Employees sign joint letter calling for Jensen Huang's return; NVIDIA Corporation (NVDA.US) rises nearly 2% in pre-market trading.

On Friday, NVIDIA Corporation (NVDA.US) rose nearly 2% in pre-market trading and is currently at $169.24.

9 h ago

FRIENDTIMES (06820) intends to subscribe for limited partnership interests in Juyuan Jiangcheng Fund and Juyuan Bowen Fund, with a total capital contribution of RMB60 million.

FRIENDTIMES (06820) announced that on April 23, 2026 and November 12, 2026, the Group entered into two partnership agreements with general partners Suzhou Juyuan Xincore and SMIC Juyuan (Ningbo), respectively, pursuant to which the Group has agreed to subscribe for limited partnership interests in Juyuan Jiangcheng Fund and Juyuan Bowen Fund, with capital contributions of RMB20 million and RMB40 million, respectively. The Group's capital contributions for the subscriptions were all funded from its own funds.

10 h ago

SHEUNG YUE GP (01633) proposes rights issue on a 2-for-1 basis.

SHEUNG YUE GP (01633) announced that the Board proposes to conduct a rights issue by way of rights issue of up to 342 million rights shares to qualifying shareholders at a subscription price of HK$0.100 per rights share on the basis of 1 rights share for every 2 shares held on the record date, to raise gross proceeds of approximately HK$34.2 million (before deducting expenses) (assuming no further issuance or repurchase of shares on or before the record date). The rights issue is only available to qualifying shareholders and will not be offered to excluded shareholders.

10 h ago

US Stock Market Move | October PPI came in below expectations; Nasdaq futures rose 0.40%; most star tech stocks gained in premarket trading.

On Friday, futures for the three major U.S. stock indices all rose, with Nasdaq futures up 0.40%, and most star tech stocks gained in premarket trading.

10 h ago

Langhua International Group (08026) announces interim results: profit attributable to owners of the company approximately HK$6.258 million, up 73.35% year-on-year.

Langhua International Group (08026) announced its interim results for the six months ended September 30, 2026: revenue of approximately HK$264 million, up approximately 490% year-on-year. Profit attributable to owners of the company was approximately HK$6.258 million, up 73.35% year-on-year; earnings per share were 4.1 HK cents.

10 h ago

160 HEALTH (02656): Backed by Both Barclays and Southbound Capital, Is the Inflection Point for Large-Scale Commercialization of AI Healthcare Near?

On that day, Barclays PLC increased its holdings by 24.182 million shares at an average price of HK$3.18 per share, involving approximately HK$76.9278 million. The positive bellwether move by the international investment bank attracted many market funds to follow suit and turn bullish, and also brought 160 HEALTH a long-awaited rally recently.

10 h ago

U.S. October PPI data came in below expectations, slightly cooling expectations for Fed rate hikes.

U.S. October headline PPI data came in below expectations, slightly cooling market bets on Fed rate hikes.

10 h ago

Global equity funds attracted US$51 billion in a single week, the highest in nearly two months! BofA breaks down the "say-one-thing-do-another" phenomenon: many are bearish, but few are actually shorting.

Although US tech stocks have suffered a sell-off and bearish voices are widespread, very few investors actually dare to "practice what they preach" and short the market.

10 h ago

After the PPI report was released, traders lowered their expectations for Federal Reserve tightening.

Latest news

10 h ago

Hong Kong's Financial Services and the Treasury Bureau: New Capital Investment Entrant Scheme expected to attract over HK$150 billion in investment; plans to broaden fund definition and tax incentives.

The Hong Kong Financial Services and the Treasury Bureau said that the New Capital Investment Entrant Scheme has been in implementation for more than two and a half years. As of the end of October this year, more than 5,000 applications had been received, and it is expected to bring over HK$150 billion in investment to Hong Kong.

10 h ago

Musk's "fully reusable rocket" ambition faces validation! SpaceX (SPCX.US) Starship test flight tomorrow to attempt "dual recovery," a key step toward large-scale launches for data centers.

SpaceX's Starship is set to launch its 15th test flight, aiming to achieve recovery of both stages and striving to become humanity's first fully reusable orbital rocket.

10 h ago

Jiangsu Hengrui Pharmaceuticals (01276): SHR-8925 for Injection Approved to Initiate Clinical Trials

Jiangsu Hengrui Pharmaceuticals (01276) announced that recently, its subsidiary Suzhou Suncadia Biopharmaceuticals Co., Ltd. received the Drug Clinical Trial Approval Notice for SHR-8925 for Injection approved and issued by the National Medical Products Administration (hereinafter referred to as the "NMPA"), and will initiate clinical trials in the near future.

10 h ago

Paul Chan: Hong Kong is expanding the coverage of insurance-linked securities and studying the introduction of a "protected cell company" structure.

At the 2026 Asian Insurance Forum, Financial Secretary Paul Chan said in his remarks that Hong Kong will consolidate the regulatory and capital foundations of the insurance industry, expand into shipping, emerging industries, and the insurance-linked securities market, and enhance the competitiveness of its international risk management center.

10 h ago

Wuxi Commercial Mansion Grand Orient (08115) reported a loss attributable to shareholders of RMB489 million for the first three quarters.

Qingda Orient (08115) announced its results for the nine months ended September 30, 2026, with revenue of RMB168.6 million, up 156.7% year on year; loss attributable to owners of the company of RMB489 million, compared with a profit of RMB4.046 million in the same period last year; basic loss per share of 227.11 cents.

10 h ago

Fed paper reveals the reality gap behind the AI boom: the productivity dividend has yet to materialize, inflation costs are emerging but limited in extent, and employment effects are difficult to quantify.

According to a research paper published by Federal Reserve staff, AI demand has driven a surge in U.S. data center investment and pushed up prices for some tech inputs, but its impact on overall productivity and employment remains limited.

10 h ago

Ricacorp: Market Expects Fed Rate Hike Next Month; Weekend Property Viewing Appointments for Hong Kong's 50 Benchmark Estates Fall 1.2%

The market expects a high probability of a Fed rate hike next month, disrupting buyers' plans to enter the market and further widening the price gap between buyers and sellers.

10 h ago

ZHENGWEI GROUP (02147) proposes to implement a capital reduction and share subdivision.

ZHENGWEI GROUP (02147) announced that as at the date of this announcement, the authorized share capital of the Company was US$160 million, divided into 800 million shares of US$0.2 each, of which 470.4 million existing shares were issued and fully paid or credited as fully paid. The Board proposed to implement the capital reduction and subdivision as follows:

10 h ago

Jiangsu Hengrui Pharmaceuticals (01276): SHR-4610 Injection and other drugs receive drug clinical trial approval notices

Jiangsu Hengrui Pharmaceuticals (01276) announced that recently, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (hereinafter referred to as the "Company") and its subsidiaries Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Suncadia Pharmaceuticals Co., Ltd., and Shanghai Hengrui Pharmaceuticals Co., Ltd. received the Drug Clinical Trial Approval Notices approved and issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") for SHR-4610 Injection, SHR-9839 (sc) for Injection, SHR-A2102 for Injection, SHR-4849 Injection, SHR-7787 Injection, and HRS-4508 Tablets, and will commence clinical trials in the near future.

10 h ago

HK SH ALLIANCE (01001) Issues Profit Warning, Expects Interim Profit Attributable to Shareholders to Decrease by Approximately 35% to 45% Year-on-Year

HK SH ALLIANCE (01001) announced that the Group expects to record profit attributable to owners of the Company for the six months ended 30 September 2026 to decrease by approximately 35% to 45% compared with approximately HK$52.9 million for the corresponding period in 2025.

10 h ago

LIVZON PHARMA (01513) will distribute a third-quarter dividend of RMB12.39 per 10 shares on December 23.

LIVZON PHARMA (01513) announced that it will distribute a third-quarter dividend of RMB12.39 per 10 shares on December 23, 2026.

10 h ago

SDHS NEW ENERGY (01250): Subsidiary enters into a finance lease agreement for power equipment and related auxiliary production facilities.

SDHS NEW ENERGY (01250) announced that on November 13, 2026, SDHS International Leasing (as lessor) entered into finance lease agreements with Taizhou Beiqing, Fuzhou Beikong, Hebei Beisong, Heyuan Huahao, Lu'an Beikong, Nantong Shoufu, Shijiazhuang Beikong and Yongzhou Beikong (each an indirectly wholly-owned subsidiary of the Company, as lessees) in respect of sale-and-leaseback arrangements for the leased assets. The leased assets are power equipment and related auxiliary production facilities owned by the lessees.

10 h ago

CAPITAL REALM (00204): Consolidated net asset value per share at the end of October was approximately HK$1.507.

CAPITAL REALM (00204) announced that as of October 31, 2026, the unaudited consolidated net asset value per share of the company was approximately HK$1.507.

10 h ago

SFSY ENERGY (00750) plans to apply for registration and issuance of targeted debt financing instruments.

SFSY ENERGY (00750) announced that, in order to broaden direct financing channels, optimize the tenor, types and structure of debt, and improve the efficiency of fund allocation, the Company plans to apply to the National Association of Financial Market Institutional Investors (NAFMII) for registration and issuance of targeted debt financing instruments (the Debt Financing Instruments), with an issuance size of not more than RMB1 billion and a tenor of not more than five years.

10 h ago

SFQ GLOBAL (01953) subsidiary enters into equipment processing agreement with Saifuxun Deyang

SFQ GLOBAL (01953) announced that on November 13, 2026, its subsidiary (Sichuan Saifuxun Shengyuan Enterprise Management Co., Ltd.) entered into an equipment processing agreement with Saifuxun Deyang, pursuant to which the subsidiary agreed to engage Saifuxun Deyang to process and manufacture the equipment (eight sets of 5MWh battery container energy storage equipment). Under the equipment processing agreement, the consideration payable by the subsidiary to Saifuxun Deyang is RMB4.735 million (tax inclusive).

10 h ago

C FIN SERVICES (00605) repurchased 4,000 shares on November 13 for HK$3,320.

C FIN SERVICES (00605) announced that on November 13, 2026, it repurchased 4,000 shares for HK$3,320.

10 h ago

Foreign media spotlight the revaluation of Chinese medical AI! Forbes provides an in-depth analysis of DeShi Technology (02526.HK): iMed-6.0 sweeps both first and second place on two international leaderboards, benchmarking against U.S.-listed Tempus AI.

On November 13, news emerged that the internationally authoritative financial media outlet Forbes recently published an in-depth feature titled "How Chinese Medical AI Is Winning Back the Market."

11 h ago

Cisco Systems, Inc. (CSCO.US) Q1 Earnings Beat Expectations, but Wall Street Analysts Aren't Buying It: AI's High Growth Can't Mask Concerns Over Slowing Orders

This "mixed" report card directly triggered Wall Street institutions to re-examine the company's valuation rationality and subsequent growth momentum.

11 h ago

MILLIONHOPE IND (01897) will pay a special dividend of HK$0.012 per share on December 14.

MILLIONHOPE IND (01897) announced that it will pay a special dividend of HK$0.012 per share for the six months ended September 30, 2026, on December 14, 2026.

11 h ago

MILLIONHOPE IND (01897) will distribute an interim dividend of HK$0.008 per share on December 14.

MILLIONHOPE IND (01897) announced that it will distribute a first interim dividend of HK$0.008 per share for the six months ended September 30, 2026, on December 14, 2026.

11 h ago

Microsoft Corporation (MSFT.US) hit by widespread service outage; U.S. cybersecurity sector rises in premarket trading

Cybersecurity stocks rose in Friday's U.S. premarket trading, buoyed by a widespread Microsoft service outage that left multiple services, including Outlook and Teams, unavailable for several hours.

11 h ago

MILLIONHOPE IND (01897) announces interim results, net profit HK$7.802 million, up approximately 7.66 times year-on-year.

MILLIONHOPE IND (01897) announced its interim results for the six months ended September 30, 2026, with revenue of approximately HK$262 million, up 82.08% year-on-year; net profit of HK$7.802 million, up approximately 7.66 times year-on-year; earnings per share of 1.94 HK cents, and proposed a first interim dividend of 0.8 HK cents per share and a special dividend of 1.2 HK cents per share.

11 h ago

AB&B BIO-TECH-B (02627): Adsorbed Tetanus Toxoid Vaccine Receives IND Approval from China's Center for Drug Evaluation

AB&B BIO-TECH-B (02627) announced that the Center for Drug Evaluation of the National Medical Products Administration (China's CDE) approved the Investigational New Drug (IND) application on November 12, 2026 for the group's self-developed adsorbed tetanus toxoid vaccine (adsorbed tetanus vaccine) candidate product.

11 h ago

A-Share Announcement Highlights | Plan to issue shares to acquire 51% of China Rare Earth Liangshan's rare earth mining and beneficiation assets; China Rare Earth Resources And Technology (000831.SZ) to resume trading on November 16

China Rare Earth plans to issue shares to acquire 51% equity in China Rare Earth Liangshan and will resume trading on November 16; Yuanjie Technology secured RMB1.744 billion in high-power laser chip orders.

11 h ago

CDB LEASING (01606) plans to procure IT computer equipment for RMB1.819 billion

CDB LEASING (01606) announced that the Company, as buyer, entered into the current product procurement agreement with the seller, Shandong Zhisuo Information Technology, on November 13, 2026. The seller agreed to sell to the buyer, and the buyer agreed to purchase, the subject matter of the current procurement, for a total consideration of approximately RMB1.819 billion (the current transaction).

11 h ago